GSK’s Breo Ellipta Gets “Snowquestered” As FDA Delays Advisory Cmte
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA missed its deadline to post the advisory committee briefing materials then postponed the meeting as a winter storm headed towards Washington.